Bin Chen1, Zheng Chen1, Yi-Shu Yang1, Gui-Lan Cai1, Xiao-Jiao Xu1, Hong-Zhi Guan2, Hai-Tao Ren2, Hou-Zhen Tuo3. 1. Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. 2. Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. 3. Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. tuohzh@sina.cn.
Abstract
BACKGROUND: Neurocysticercosis (NCC) is the most common helminthic infection of the central nervous system (CNS) caused by the larval stage of Taenia solium. Accurate and early diagnosis of NCC remains challenging due to its heterogeneous clinical manifestations, neuroimaging deficits, variable sensitivity, and specificity of serological tests. Next-generation sequencing (NGS)-based pathogen analysis in patient's cerebrospinal fluid (CSF) with NCC infection has recently been reported indicating its diagnostic efficacy. In this case study, we report the diagnosis of a NCC patient with a symptomatic history of over 20 years using NGS analysis and further confirmation of the pathology by immunological tests. CASE PRESENTATION: This study reports the clinical imaging and immunological features of a patient with a recurrent headache for more than 20 years, which worsened gradually with the symptom of fever for more than 7 years and paroxysmal amaurosis for more than 1 year. By utilizing NGS technique, the pathogen was detected in patient's CSF, and the presence of Taenia solium-DNA was confirmed by a positive immunological reaction to cysticercus IgG antibody in CSF and serum samples. The symptoms of the patient were alleviated, and the CSF condition was improved substantially after the anti-helminthic treatment. CONCLUSIONS: This study suggests that combining CSF NGS with cysticercus IgG testing may be a highly promising approach for diagnosing the challenging cases of NCC. Further studies are needed to evaluate the parasitic DNA load in patients' CSF for the diagnosis of disease severity, stage, and monitoring of therapeutic responses.
BACKGROUND:Neurocysticercosis (NCC) is the most common helminthic infection of the central nervous system (CNS) caused by the larval stage of Taenia solium. Accurate and early diagnosis of NCC remains challenging due to its heterogeneous clinical manifestations, neuroimaging deficits, variable sensitivity, and specificity of serological tests. Next-generation sequencing (NGS)-based pathogen analysis in patient's cerebrospinal fluid (CSF) with NCC infection has recently been reported indicating its diagnostic efficacy. In this case study, we report the diagnosis of a NCC patient with a symptomatic history of over 20 years using NGS analysis and further confirmation of the pathology by immunological tests. CASE PRESENTATION: This study reports the clinical imaging and immunological features of a patient with a recurrent headache for more than 20 years, which worsened gradually with the symptom of fever for more than 7 years and paroxysmal amaurosis for more than 1 year. By utilizing NGS technique, the pathogen was detected in patient's CSF, and the presence of Taenia solium-DNA was confirmed by a positive immunological reaction to cysticercus IgG antibody in CSF and serum samples. The symptoms of the patient were alleviated, and the CSF condition was improved substantially after the anti-helminthic treatment. CONCLUSIONS: This study suggests that combining CSF NGS with cysticercus IgG testing may be a highly promising approach for diagnosing the challenging cases of NCC. Further studies are needed to evaluate the parasitic DNA load in patients' CSF for the diagnosis of disease severity, stage, and monitoring of therapeutic responses.
Entities:
Keywords:
Amaurosis; Case report; Cysticercus IgG; Headache; Long history; Neurocysticercosis; Next-generation sequencing; Taenia solium
Authors: Michael R Wilson; Samia N Naccache; Erik Samayoa; Mark Biagtan; Hiba Bashir; Guixia Yu; Shahriar M Salamat; Sneha Somasekar; Scot Federman; Steve Miller; Robert Sokolic; Elizabeth Garabedian; Fabio Candotti; Rebecca H Buckley; Kurt D Reed; Teresa L Meyer; Christine M Seroogy; Renee Galloway; Sheryl L Henderson; James E Gern; Joseph L DeRisi; Charles Y Chiu Journal: N Engl J Med Date: 2014-06-04 Impact factor: 91.245
Authors: Arturo Carpio; Agnès Fleury; Matthew L Romo; Ronaldo Abraham; Jaime Fandiño; Juan C Durán; Graciela Cárdenas; Jorge Moncayo; Cleonísio Leite Rodrigues; Daniel San-Juan; Marcos Serrano-Dueñas; Oswaldo Takayanagui; Josemir W Sander Journal: Ann Neurol Date: 2016-08-13 Impact factor: 10.422
Authors: Arturo Carpio; Alfredo Campoverde; Matthew L Romo; Lorena García; Luis M Piedra; Mónica Pacurucu; Nelson López; Jenner Aguilar; Sebastian López; Luis C Vintimilla; Ana M Toral; Pablo Peña-Tapia Journal: Neurol Neuroimmunol Neuroinflamm Date: 2017-01-16